Diagnostics News and Research

RSS

Researchers develop versatile machine learning tool to automate complex clinical diagnostics

A research team funded by the National Institutes of Health (NIH) has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease.

4 Mar 2026

Mursla Bio accelerates US commercial deployment of EvoLiver through ABHI program

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve chronic disease outcomes for at-risk patients, today announced it has been selected to join the Association of British HealthTech Industries (ABHI) US Accelerator.

4 Mar 2026

New collaboration explores familial inflammatory bowel disease in Saudi Arabia

Mount Sinai and King Saud University Medical City in Riyadh, Saudi Arabia, today announced a three-year collaboration aimed at better understanding why inflammatory bowel disease (IBD) runs in some Saudi families, and how that knowledge can lead to risk ascertainment, earlier diagnosis and more personalized treatment options.

3 Mar 2026

AI cancer tools may be using visual shortcuts rather than true biology

New research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.

2 Mar 2026

Wisdom Bioscience establishes Scientific Advisory Board to advance oral cancer diagnostics and screening

Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB) following the close of an initial funding round.

2 Mar 2026

Imaging technique can objectively identify a recently recognized type of dementia, LATE

A novel quantitative PET- and MRI-based imaging approach can objectively identify a recently recognized type of dementia--limbic-predominant age-related TDP-43 encephalopathy, or LATE--that is often mistaken as Alzheimer's disease.

26 Feb 2026

Study highlights systemic forces sustaining tuberculosis transmission

Despite major advances in diagnostics and treatment, tuberculosis (TB) remains the world's deadliest infectious disease.

26 Feb 2026

Extra copies of chromosome 1q may play key role in the earliest stages of pancreatic cancer

Researchers at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center uncovered new evidence that extra copies of a specific chromosome segment - chromosome 1q - may play a key role in the earliest stages of pancreatic cancer development.

26 Feb 2026

New laser technique ensures integrity of mRNA therapeutics

Messenger RNA (mRNA) technology is transforming medicine by providing our cells with genetic instructions to produce proteins that help the immune system prevent or fight a wide range of diseases, including cancer and other rare disorders.

26 Feb 2026

New Mandarin cognitive tests improve dementia diagnosis for Chinese older adults

Asian Americans are the fastest-growing group of older adults in the U.S., but they often face language and cultural barriers when seeking care for dementia-related symptoms.

26 Feb 2026

New daily tablet simplifies long-term HIV care

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors, according to the results of a new phase 3 clinical trial published in The Lancet.

26 Feb 2026

Experimental antibiotics disrupt bacterium that causes tuberculosis

Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments.

25 Feb 2026

Study finds brain changes related to worse memory in football players with repetitive head impacts

In former college and professional football players, a new study has found higher levels of inflammation were associated with worse brain structure, which in turn was related to worse memory.

25 Feb 2026

Centauri Therapeutics extends Series A to £30 M with £6 M investment from AMR Action Fund to support progression of lead clinical candidate

Centauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, today announced it has secured £6 M from AMR Action Fund, extending the Company's Series A round to £30 M.

24 Feb 2026

Innovating Texture and Culture in Plant-Based Foods

Discover how Thermo Fisher is shaping the future of plant-based foods through texture innovation and cultural relevance.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 24 Feb 2026

Danaher to acquire Masimo Corporation

Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings.

From Danaher Life Sciences 24 Feb 2026

Advantech highlights real-time medical edge AI at HIMSS 2026

Advantech, a global leader in embedded and Internet of Things (IoT) solutions, will showcase its latest healthcare AI innovations at the HIMSS 2026 Global Health Conference & Exhibition, March 9–12, 2026, in Las Vegas, Nevada.

From Advantech 24 Feb 2026

Detecting the "scent" of ovarian cancer with AI

Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, according to the LiU researchers behind the study, it could eventually be used to find many different cancers. The study is published in the scientific journal Advanced intelligent systems.

23 Feb 2026

Study finds microplastics in most prostate tumors

Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds.

23 Feb 2026

Syndex Bio unveils mcPCR technology at AGBT 2026 following $15.5 M seed financing

Syndex Bio, a biotechnology company advancing next‑generation molecular diagnostics, today announced the introduction of its proprietary mcPCR™ (methyl‑copying PCR) platform at the Advances in Genome Biology and Technology (AGBT) conference in Orlando, Florida.

23 Feb 2026

Diagnostics News and Research

Researchers develop versatile machine learning tool to automate complex clinical diagnostics

Mursla Bio accelerates US commercial deployment of EvoLiver through ABHI program

New collaboration explores familial inflammatory bowel disease in Saudi Arabia

AI cancer tools may be using visual shortcuts rather than true biology

Wisdom Bioscience establishes Scientific Advisory Board to advance oral cancer diagnostics and screening

Imaging technique can objectively identify a recently recognized type of dementia, LATE

Study highlights systemic forces sustaining tuberculosis transmission

Extra copies of chromosome 1q may play key role in the earliest stages of pancreatic cancer

New laser technique ensures integrity of mRNA therapeutics

New Mandarin cognitive tests improve dementia diagnosis for Chinese older adults

New daily tablet simplifies long-term HIV care

Experimental antibiotics disrupt bacterium that causes tuberculosis

Study finds brain changes related to worse memory in football players with repetitive head impacts

Centauri Therapeutics extends Series A to £30 M with £6 M investment from AMR Action Fund to support progression of lead clinical candidate

Innovating Texture and Culture in Plant-Based Foods

Danaher to acquire Masimo Corporation

Advantech highlights real-time medical edge AI at HIMSS 2026

Detecting the "scent" of ovarian cancer with AI

Study finds microplastics in most prostate tumors

Syndex Bio unveils mcPCR technology at AGBT 2026 following $15.5 M seed financing

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News